Krka, d. d.
KRK
Pozycja w akcjach
#2128
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
Cena akcji
$318.12
Kapitalizacja rynkowa
$9.63B
Zmiana (1 dzień)
0.18%
Zmiana (1 rok)
32.75%
Kraj
SI
Handel Krka, d. d. (KRK)
Kategoria
Healthcare
Zyski dla Krka, d. d. (KRK)
Zyski w Jun 2026 TTM: $613.56M
Według najnowszych raportów finansowych Krka, d. d., obecny zysk firmy wynosi $613.56M. W roku 2023 firma osiągnęła zysk w wysokości $405.84M, spadek w porównaniu do zysku z roku 2022, który wynosił $464.55M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Krka, d. d. od 2010 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $613.56M | 40.70% |
| 2024 | $436.08M | 7.45% |
| 2023 | $405.84M | -12.64% |
| 2022 | $464.55M | 12.72% |
| 2021 | $412.12M | -0.18% |
| 2020 | $412.85M | 29.40% |
| 2019 | $319.06M | 37.06% |
| 2018 | $232.79M | 10.12% |
| 2017 | $211.39M | 72.75% |
| 2016 | $122.37M | -37.64% |
| 2015 | $196.22M | -7.49% |
| 2014 | $212.12M | -23.39% |
| 2013 | $276.88M | 10.18% |
| 2012 | $251.29M | -2.93% |
| 2011 | $258.87M | -8.40% |
| 2010 | $282.60M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 187.59% |
IN
|
